News

BioAdvance WorkShop

Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity
Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
Immunome Reports First Quarter 2023 Financial Results
VESTECK SAB Member Accepts International Leadership Appointment
SIRPant Immunotherapeutics Announces FDA Clearance of IND Application for SIRPant-M™ Autologous SIRPαlow Activated Macrophage Immunotherapy